• Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Jenburph Share Price

    Jenburkt Pharmaceuticals Share PriceJenburkt Pharmaceuticals

    Small Cap 1.4k Result
    ₹676.25
    4.5 (0.67%)
    As on 29 November, 2023 | 01:17 BSE: 524731 NSE: JENBURPHISIN: INE354A01013

    Jenburkt Pharmaceuticals Performance

    Day Range

    • Low
    • High
    676.25

    52 Week Range

    • Low
    • High
    676.25
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Jenburkt Pharmaceuticals

    Start SIP

    Jenburkt Pharmaceuticals Share Price

    • Over 1 Month 7.01%
    • Over 3 Month -4.34%
    • Over 6 Month -12.57%
    • Over 1 Year 14.09%

    Jenburkt Pharmaceuticals Key Statistics

    Jenburkt Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 38293535363128
    Operating Expenses Qtr Cr 29222828272424
    Operating Profit Qtr Cr 9777975
    Depreciation Qtr Cr 1111111
    Interest Qtr Cr 0000000
    Tax Qtr Cr 2222222
    Net Profit Qtr Cr 7565763
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 142129
    Operating Expenses Annual Cr 10697
    Operating Profit Annual in Cr 3027
    Depreciation Cr 22
    Interest Annual Cr 00
    Tax Annual Cr 88
    Net Profit Annual Cr 2522
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 9
    Cash from Investing Activity Annual Cr -1
    Cash from Financing Annual Activity Cr -6
    Net Cash Flow Annual Cr 3
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 122117
    Fixed Assets Annual Cr 1112
    Total Non Current Assets Annual Cr 6167
    Total Current Assets Annual Cr 8176
    Total Assets Annual Cr 142143
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 277256
    ROE Annual % 2019
    ROCE Annual % 2625
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2626
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Jenburkt Pharmaceuticals

    Jenburkt Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹676.25
    4.5 (0.67%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹670.02
    • 50 Day
    • ₹674.06
    • 100 Day
    • ₹684.46
    • 200 Day
    • ₹678.93
    • 20 Day
    • ₹662.9
    • 50 Day
    • ₹670.27
    • 100 Day
    • ₹699.75
    • 200 Day
    • ₹694.73

    Jenburkt Pharmaceuticals Resistance and Support

    PIVOT
    ₹674.65
    Resistance
    First Resistance ₹688.3
    Second Resistance ₹700.35
    Third Resistance ₹714
    RSI 54.16
    MFI 74.86
    MACD Single Line 3
    MACD 4.67
    Support
    First Resistance ₹662.6
    Second Resistance ₹648.96
    Third Resistance ₹636.9

    Jenburkt Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,488 231,210 92.93
    Week 2,168 196,703 90.73
    1 Month 2,620 223,268 85.22
    6 Month 2,408 197,825 82.17

    Jenburkt Pharmaceuticals Result Highlights

    Jenburkt Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Jenburkt Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-07 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-23 Audited Results, Dividend & A.G.M.
    2023-02-07 Quarterly Results
    2022-12-01 Buy Back of Shares

    Jenburkt Pharmaceuticals FAQs

    What is Share Price of Jenburkt Pharmaceuticals ?

    Jenburkt Pharmaceuticals share price is ₹676 As on 29 November, 2023 | 01:03

    What is the Market Cap of Jenburkt Pharmaceuticals ?

    The Market Cap of Jenburkt Pharmaceuticals is ₹298.4 Cr As on 29 November, 2023 | 01:03

    What is the P/E ratio of Jenburkt Pharmaceuticals ?

    The P/E ratio of Jenburkt Pharmaceuticals is 12.2 As on 29 November, 2023 | 01:03

    What is the PB ratio of Jenburkt Pharmaceuticals ?

    The PB ratio of Jenburkt Pharmaceuticals is 2.4 As on 29 November, 2023 | 01:03

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.